Skip to main content

Bank of New York Mellon Corp

Bank

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY

Position in AMLX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,490,343
+$864,792 QoQ
Shares Held
251,104
+15.5% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 80% Shared 0% None 20%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $1,372,047,844 across 46 Drug Manufacturers - Specialty & Generic names. AMLX ranks #23 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,490,343 251,104
2025-12-31 $2,625,551 217,347
2025-09-30 $2,486,370 182,956
2025-06-30 $966,864 150,837
2024-09-30 $76,719 23,679
2024-03-31 $562,400 198,029
2023-12-31 $2,811,518 191,000
2023-09-30 $2,995,423 163,595
2023-06-30 $3,534,912 163,881
2023-03-31 $6,004,605 204,656
2022-12-31 $7,764,633 210,139
2022-09-30 $3,291,972 116,944
2022-06-30 $558,944 29,021
2022-03-31 $339,894 26,451